| 摘要 |
1. A pharmaceutical composition comprising: a) an LHRH peptide agonist, an LHRH antagonist or a growth hormone releasing factor peptide as active ingredient; b) nicotinamide; and c) a physiological aqueous solution. 2. The pharmaceutical composition according to claim 1, wherein the active ingredient is an LHRH peptide antagonist. 3. The pharmaceutical composition according to claim 1 or claim 2, wherein the active ingredient is Antide or human GRF. 4. The pharmaceutical composition according to any one of claims 1 to 3, which is lyophilised and reconstitutable and further comprises one or more stabilizing agents. 5. The pharmaceutical composition according to any one of claims 1 to .4, which further comprises propylene glycol. 6. The pharmaceutical composition according to any one of claims 1 to 5, which is suitable for parenteral, oral, nasal or pulmonary administration route. 7. The pharmaceutical composition according to any one of claims 1 to 6, further comprising one or more pharmaceutically acceptable excipients. 8. The pharmaceutical composition according to any one of claims 1 to 7, which is suitable for injections. 9. The pharmaceutical composition according to any one of claims 1 to 8, which has the following composition ranges: antide or hGRF 0.1 - 20.0 mg nicotinamide 10 - 300 mg propylene glycol 0 - 800 mg aqueous phase, q.s. 1.0 ml. |
